Atherosclerotic cardiovascular diseases (CVD) are the most common causes of death and disability in the developed countries. Atherosclerosis is a chronic inflammatory disease, characterized by lipid accumulation in macrophages of arterial walls. ATP-binding cassette (ABC) transporters A1 (ABCA1) and G1 (ABCG1) are essential for preventing macrophages from developing into ?foam? cells by promoting cholesterol efflux to lipid-free apoA-I or HDL, which subsequently delivers macrophage-derived cholesterol to the liver and intestinal lumen for excretion to the feces. Defective cholesterol efflux leads to formation of foam macrophages, which are activated to contribute to the inflammatory response during atherogenesis. MicroRNAs (miRNAs) are short, non-coding RNAs that bind to the 3'UTR of mRNAs to post-transcriptionally regulate gene expression. Recent studies have documented miRNAs as important regulators of lipid metabolism. We have generated miR-34a???Apoe??? double knockout (DKO) mice. Upon fed a Western diet, the DKO mice have a marked reduction in atherosclerotic lesions in both the aorta and aortic root as compared to Apoe????mice, which is accompanied by unchanged plasma LDL-C or HDL-C levels. Further studies show that miR-34a??? macrophages have a striking increase in Abca1 and Abcg1 expression and are protective against inflammatory response. Based on our preliminary studies, we hypothesize that inhibition of miR-34a protects against atherosclerosis by increasing macrophage reverse cholesterol transport and inhibiting inflammation. To test this hypothesis, we propose three specific aims to determine whether macrophage miR-34a regulates cholesterol efflux and reverse cholesterol transport, inflammation and atherosclerosis. We will use genetically modified mice and pharmacological manipulations together with state-of-the-art techniques to complete this project. Completion of the proposed studies may uncover a novel role of macrophage miR-34a in cholesterol metabolism, inflammation and atherosclerosis, and may also lead to identification of miR-34a as a novel target for prevention and/or regression of atherosclerosis.

Public Health Relevance

Relevance: Atherosclerotic cardiovascular disease is the leading cause of deaths and disability in the Western countries. Completion of the proposed studies will help determine the role of macrophage miR-34a in progression and regression of atherosclerosis, and may lead to a new strategy for treatment of atherosclerosis. Thus, the studies proposed in this application are highly relevant to human health.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL103227-06
Application #
9310434
Study Section
Atherosclerosis and Inflammation of the Cardiovascular System Study Section (AICS)
Program Officer
Liu, Lijuan
Project Start
2010-12-01
Project End
2020-06-30
Budget Start
2017-07-01
Budget End
2018-06-30
Support Year
6
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Northeast Ohio Medical University
Department
Other Basic Sciences
Type
Schools of Medicine
DUNS #
077779882
City
Rootstown
State
OH
Country
United States
Zip Code
44272
Jamaiyar, Anurag; Juguilon, Cody; Dong, Feng et al. (2018) Cardioprotection during Ischemia by Coronary Collateral Growth. Am J Physiol Heart Circ Physiol :
Singh, Amar Bahadur; Dong, Bin; Kraemer, Fredric B et al. (2018) Farnesoid X Receptor Activation by Obeticholic Acid Elevates Liver Low-Density Lipoprotein Receptor Expression by mRNA Stabilization and Reduces Plasma Low-Density Lipoprotein Cholesterol in Mice. Arterioscler Thromb Vasc Biol 38:2448-2459
Jadhav, Kavita; Xu, Yang; Xu, Yanyong et al. (2018) Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR. Mol Metab 9:131-140
Jadhav, Kavita; Zhang, Yanqiao (2017) Activating transcription factor 3 in immune response and metabolic regulation. Liver Res 1:96-102
You, Min; Jogasuria, Alvin; Lee, Kwangwon et al. (2017) Signal Transduction Mechanisms of Alcoholic Fatty Liver Disease: Emer ging Role of Lipin-1. Curr Mol Pharmacol 10:226-236
Park, Jung Eun; Lee, Mikang; Kim, Seong-Chul et al. (2017) Hairy and enhancer of split 6 prevents hepatic lipid accumulation through inhibition of Pparg2 expression. Hepatol Commun 1:1085-1098
Zhang, Guoning; Liu, Shuainan; Tan, Wenjuan et al. (2017) Synthesis and biological evaluations of chalcones, flavones and chromenes as farnesoid x receptor (FXR) antagonists. Eur J Med Chem 129:303-309
Shi, Xin; Zhang, Weihong; Yin, Liya et al. (2017) Vascular precursor cells in tissue injury repair. Transl Res 184:77-100
Jamaiyar, A; Wan, W; Janota, D M et al. (2017) The versatility and paradox of GDF 11. Pharmacol Ther 175:28-34
Xu, Jiesi; Xu, Yang; Xu, Yanyong et al. (2017) Global inactivation of carboxylesterase 1 (Ces1/Ces1g) protects against atherosclerosis in Ldlr -/- mice. Sci Rep 7:17845

Showing the most recent 10 out of 23 publications